Correlation Between Larimar Therapeutics and ZyVersa Therapeutics
Can any of the company-specific risk be diversified away by investing in both Larimar Therapeutics and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Larimar Therapeutics and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Larimar Therapeutics and ZyVersa Therapeutics, you can compare the effects of market volatilities on Larimar Therapeutics and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Larimar Therapeutics with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Larimar Therapeutics and ZyVersa Therapeutics.
Diversification Opportunities for Larimar Therapeutics and ZyVersa Therapeutics
0.06 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Larimar and ZyVersa is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Larimar Therapeutics and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and Larimar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Larimar Therapeutics are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of Larimar Therapeutics i.e., Larimar Therapeutics and ZyVersa Therapeutics go up and down completely randomly.
Pair Corralation between Larimar Therapeutics and ZyVersa Therapeutics
Given the investment horizon of 90 days Larimar Therapeutics is expected to generate 0.5 times more return on investment than ZyVersa Therapeutics. However, Larimar Therapeutics is 2.01 times less risky than ZyVersa Therapeutics. It trades about -0.09 of its potential returns per unit of risk. ZyVersa Therapeutics is currently generating about -0.15 per unit of risk. If you would invest 735.00 in Larimar Therapeutics on August 24, 2024 and sell it today you would lose (122.00) from holding Larimar Therapeutics or give up 16.6% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Larimar Therapeutics vs. ZyVersa Therapeutics
Performance |
| Timeline |
| Larimar Therapeutics |
| ZyVersa Therapeutics |
Larimar Therapeutics and ZyVersa Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Larimar Therapeutics and ZyVersa Therapeutics
The main advantage of trading using opposite Larimar Therapeutics and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Larimar Therapeutics position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.| Larimar Therapeutics vs. Vaxcyte | Larimar Therapeutics vs. Syndax Pharmaceuticals | Larimar Therapeutics vs. Merus BV | Larimar Therapeutics vs. Sutro Biopharma |
| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets |